The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(6,7-Dimethoxy-quinazolin-4-yl)-2,5-dimethyl-piperazine-1-carboxylic acid (4-phenoxy-phenyl)-amide ID: ALA337363
PubChem CID: 10984087
Max Phase: Preclinical
Molecular Formula: C29H31N5O4
Molecular Weight: 513.60
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc2ncnc(N3CC(C)N(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3C)c2cc1OC
Standard InChI: InChI=1S/C29H31N5O4/c1-19-17-34(29(35)32-21-10-12-23(13-11-21)38-22-8-6-5-7-9-22)20(2)16-33(19)28-24-14-26(36-3)27(37-4)15-25(24)30-18-31-28/h5-15,18-20H,16-17H2,1-4H3,(H,32,35)
Standard InChI Key: OCDACLBUQAZWKJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
3.8625 -2.3292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8667 -3.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8625 -0.8167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2167 -3.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8625 -0.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5167 -1.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2125 -1.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2167 -4.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5625 -3.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2125 -1.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5167 -1.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5250 -3.4542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5167 0.3208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5625 -4.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9042 -3.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9042 -4.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8750 -4.6000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5292 -4.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2042 0.3208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2792 -0.9167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1750 -0.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5792 -0.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2542 -3.0917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2500 -4.6042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3792 -1.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7750 0.4083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2792 -0.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4750 0.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9792 -1.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5625 -2.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9875 -0.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6000 -4.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7792 -2.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5625 -3.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0792 -1.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8875 -2.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1917 -2.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5875 -3.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 7 1 0
4 2 1 0
5 3 1 0
6 1 1 0
7 10 1 0
8 4 1 0
9 4 2 0
10 1 1 0
11 6 1 0
12 2 2 0
13 5 1 0
14 8 2 0
15 9 1 0
16 15 2 0
17 18 2 0
18 12 1 0
19 5 2 0
20 22 1 0
21 13 1 0
22 29 1 0
23 15 1 0
24 16 1 0
25 20 1 0
26 21 2 0
27 21 1 0
28 26 1 0
29 27 2 0
30 10 1 0
31 11 1 0
32 24 1 0
33 25 2 0
34 23 1 0
35 25 1 0
36 33 1 0
37 35 2 0
38 37 1 0
3 11 1 0
17 8 1 0
14 16 1 0
22 28 2 0
38 36 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 513.60Molecular Weight (Monoisotopic): 513.2376AlogP: 5.57#Rotatable Bonds: 6Polar Surface Area: 89.05Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.85CX Basic pKa: 5.34CX LogP: 5.13CX LogD: 5.12Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.36Np Likeness Score: -0.91
References 1. Matsuno K, Nakajima T, Ichimura M, Giese NA, Yu JC, Lokker NA, Ushiki J, Ide S, Oda S, Nomoto Y.. (2002) Potent and selective inhibitors of PDGF receptor phosphorylation. 2. Synthesis, structure activity relationship, improvement of aqueous solubility, and biological effects of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives., 45 (20): [PMID:12238930 ] [10.1021/jm0201114 ]